111 – 120 of 4981
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
- Contribution to journal › Article
-
Mark
Kloka kliniska val och hälsoekonomiska utvärderingar
(2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
-
Mark
Why are not all paediatric cancer patients treated with protons? A population-based report from Sweden, 2016–2023
- Contribution to journal › Article
-
Mark
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
- Contribution to journal › Article
-
Mark
Molecular Subtypes of Muscle-Invasive Bladder Cancer
(2025) p.279-295
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Pre- or postoperative radiotherapy for oral cancer - Does the treatment order matter?
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
(2025) In FEBS Open Bio
- Contribution to journal › Article
-
Mark
Statin Therapy in Early Breast Cancer : The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo
- Contribution to journal › Article
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
